Company intelligence / Profile preview

Plasma Surgical

Roswell, Georgia, United Statestheplasmajet.com ↗

Ownership: Private
Employees: ~27
Development stage: Commercial

Overview

Plasma Surgical’s flagship product, the PlasmaJet system, is a neutral plasma surgery device cleared for use in the US and EU. It enables efficient cutting, coagulation, and ablation of tissue with minimal thermal spread. Over 40,000 patients have been treated globally across more than 20 countries. The company holds a robust patent portfolio supporting its proprietary technology.

Therapeutic areas: OtherOncologyWomen's Health
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Plasma Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma Surgical.

Explore the full profile